oncology
Charity launches second cancer research game
October 9, 2014Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds
Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …
Novartis says three executives departing firm
October 9, 2014Medical Communications, Sales and Marketing Andrin Oswald, Brian McNamara, GSK, George Gunn, Novartis, lilly, oncology, vaccines
Swiss pharma giant Novartis has announced three of its executives are to leave the firm following deals with Lilly and …
NHS England consults on Cancer Drugs Fund
October 6, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology
NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …
Roche falls foul of NICE rules, again
October 3, 2014Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology
Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …
Half of cancers diagnosed at late stage
September 22, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, oncology
A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …
Gilead’s blood cancer pill approved in Europe
September 22, 2014Sales and Marketing CLL, Gilead, blood cancer, fl, idelalisib, oncology, zydelig
Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further …
Boehringer pays $600m for cancer vaccine deal
September 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1
Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …
Cancer drug gains first early UK access grant
September 17, 2014Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising
A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
NHS cancer services not holding up, says report
September 8, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology
NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …
MedImmune to work with biotech Advaxis on cancer
July 22, 2014Research and Development, Sales and Marketing Advaxis, AstraZeneca, Cancer, MEDI4736, MedImmune, oncology, pd1
AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …
Genentech to buy Seragon
July 3, 2014Sales and Marketing Genentech, Roche, breast cancer, oncology, serds
Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …
PD-1 cancer race heats up as Merck takes lead
July 2, 2014Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab
Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …
Doctors who miss cancer to be named and shamed
July 1, 2014Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology
In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …
Value tops the agenda at ASCO cancer conference
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology
The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …
Novartis emphasises pharma growth
June 19, 2014Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory
Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …
